Bioethics, Ltd.
BOTH · OTC
12/31/2024 | 9/30/2024 | 6/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Market Cap | $3,835 | $2,327 | $2,554 | $1,362 |
| - Cash | $15 | $17 | $10 | $0 |
| + Debt | $586 | $496 | $492 | $449 |
| Enterprise Value | $4,406 | $2,806 | $3,036 | $1,811 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$123 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| Net Income | -$48 | -$53 | -$36 | -$40 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.015 | -0.047 | -0.032 | -0.035 |
| % Growth | 69% | -47.6% | 9.2% | – |
| Operating Cash Flow | -$72 | -$39 | -$33 | -$6 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$72 | -$39 | -$33 | -$6 |